Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Sygnature is exhibiting at ELRIG’s Drug Discovery 2016 event at the ACC, Liverpool. Stand G1

Drug Discovery 2016 will bring together 1000 delegates and 50 world-class speakers from academia and industry, each representing critical areas in drug discovery.

Scientific Sessions:
Innovations in Chemistry
Oncology & Immunology
Innovations in Predictive & Translational Models
Assay Development, Screening & Emerging Technologies
Coming Closer to the Patient – Cells & Genes in Therapy & Diagnostics
Target Identification & Validation

Plenary Keynote Speakers:
Professor Chas Bountra
Chief Scientist (SGC), Professor of Translational Medicine, University of Oxford

Professor Munir Pirmohamed
David Weatherall Chair in Medicine, Royal Liverpool University Hospital

Professor Dame Carol Robinson OBE
Professor of Chemistry, University of Oxford

Latest News

View All

Sygnature Discovery completes acquisition of SB Drug…

Sygnature Discovery partners the Oncology Development Programme…

Sygnature Discovery deploys Iktos’ AI technology ‘Makya™’

Sygnature Discovery acquires Peak Proteins

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

Areas of interest

Discovery Discipline
Therapeutic Areas
The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.